Fig. 4From: The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysisThe relevant rank plots based on probabilities of interventions. a Overall survival. b Progression-free survival. c Total severe adverse eventsBack to article page